XML 82 R41.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summary of significant accounting policies (Product Warranty Liability) (Details) (USD $)
In Millions, except Per Share data, unless otherwise specified
3 Months Ended
Jan. 31, 2012
Jan. 31, 2011
Oct. 31, 2011
Accrued Product Warranty And Deferred Warranty Revenue, Standard And Extended Warranty Programs, Roll Forward:      
Accrued product warranty and deferred warranty revenue, at beginning of period $ 598 $ 506  
Cost accrued and revenues deferred 111 81  
Adjustments to pre-existing warranties 123 [1] 9 [1]  
Payments and revenues recognized (106) (90)  
Accrued product warranty and deferred warranty revenue, at end of period 726 506  
Accrued product warranty and deferred warranty revenue 726 506  
Less: Current portion 324 250  
Noncurrent accrued product warranty and deferred warranty revenue 402 256  
Adjustments to pre-existing warranties, per diluted share $ 1.76    
Product Warranty Accrual, Preexisting Increase (Decrease), net of tax 81    
Product Warranty Accrual, Preexisting Increase Decrease Per Share, Net of Tax $ 1.16    
Extended Warranty Program:      
Extended warranty program deferred revenue 282   257
Revenue recognized under extended warranty programs $ 15 $ 12  
[1] Adjustments to pre-existing warranties reflect changes in our estimate of warranty costs for products sold in prior periods. Such adjustments typically occur when claims experience deviates from historic and expected trends. Our warranty liability is generally affected by component failure rates, repair costs, and the timing of failures. Future events and circumstances related to these factors could materially change our estimates and require adjustments to our liability. In addition, new product launches require a greater use of judgment in developing estimates until historical experience becomes available. In the first quarter of 2012, we recorded adjustments for changes in estimates of $123 million, or $1.76 per diluted share. Net of tax, the adjustments for changes in estimates amounted to $81 million, or $1.16 per diluted share.